PATENT CLAIM ANALYSIS

Application Number: 15958307
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "468000"]

Abstract:
The present invention relates to the treatment and/or prophylaxis of obesity and/or an NADPH superoxide anion (O 2 . − ) associated cardiovascular disease.

Claim (Index 4):
The method of  claim 1 , wherein the active agent is administered in such a concentration that in vivo the following concentration is achieved:\n approximately \u226520 \u03bcM Bay 11-7082, or approximately \u226550 \u03bcM parthenolide, or approximately \u2265140 \u03bcM DMF.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14131049', '14236879', '14358571', '10487091', '10927742']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6874068602153672
- 35 USC 102 Novelty (BERT): 0.4776971081295835
- Combined Prediction Score: 0.6664358850067889
- Mean Citation Score: 119.089578
- Max Citation Score: 123.73654
- Similarity Product: 87.38253111351369

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test